Artificial intelligence drives the identification and screening of novel antibiotics and antimicrobial peptides
Briefings in Bioinformatics · 01.03.2026 · 27 (2)
DOI: 10.1093/bib/bbag107 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 14.04.2026. Verfasst von Qi Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Laboratory of Veterinary Drug Residues (HZAU), Huazhong Agricultural University, 1 Shizishan Street, Hongshan District, Wuhan, Hub…. Hauptthemen laut MEDLINE: Artificial Intelligence, Antimicrobial Peptides, Anti-Bacterial Agents, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hubei Key Research and Development Program Project.
Abstract (Originalsprache)
The discovery of new antimicrobial drugs has become urgent due to the growing threat of antimicrobial resistance in the 21st century. However, high-throughput screening is costly and time-consuming. Artificial intelligence (AI) can facilitate the discovery of novel antibiotics and antimicrobial peptides (AMPs) by accelerating identification and reducing development costs. This review focuses on the application of artificial intelligence in the discovery of novel antibiotics and AMPs, highlighting recent advances and practical strategies in AI-driven antibacterial drug development. Ultimately, this article aims to provide practical support and guidance for researchers in antimicrobial discovery, thereby contributing to resolving the global health crisis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Reference Laboratory of Veterinary Drug Residues (HZAU), Huazhong Agricultural University, 1 Shizishan Street, Hongshan District, Wuhan, Hubei 430070, China.
- National Laboratory for Veterinary Drug Safety Evaluation, Huazhong Agricultural University, 1 Shizishan Street, Hongshan District, Wuhan, Hubei 430070, China.
- MOA Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, 1 Shizishan Street, Hongshan District, Wuhan, Hubei 430070, China.
- College of Veterinary Medicine, Huazhong Agricultural University, 1 Shizishan Street, Hongshan District, Wuhan, Hubei 430070, China.
- Hubei Jiangxia Laboratory, 9 Tangxunhu North Road, Jiangxia District, Wuhan, Hubei 430200, China.
ORCID-Profile: Lingli Huang
Förderung
- Hubei Key Research and Development Program Project
Zitieren
APA
Zhou, Q., Sun, L., Ou, Y., Liu, H., Gao, J., Dai, R., Li, Y., Cheng, G., Tao, Y., Pan, Y., & Huang, L. (2026). Artificial intelligence drives the identification and screening of novel antibiotics and antimicrobial peptides. Briefings in Bioinformatics, 27(2). https://doi.org/10.1093/bib/bbag107
Vancouver
Zhou Q, Sun L, Ou Y, Liu H, Gao J, Dai R, et al. Artificial intelligence drives the identification and screening of novel antibiotics and antimicrobial peptides. Briefings in Bioinformatics. 2026;27(2). doi:10.1093/bib/bbag107
BibTeX
@article{Zhou2026,
author = {Zhou, Qi and Sun, Lei and Ou, Yanhong and Liu, Haiyan and Gao, Jingjie and Dai, Renhui and Li, Yan and Cheng, Guyue and Tao, Yanfei and Pan, Yuanhu and Huang, Lingli},
title = {Artificial intelligence drives the identification and screening of novel antibiotics and antimicrobial peptides},
journal = {Briefings in Bioinformatics},
year = {2026},
volume = {27},
number = {2},
doi = {10.1093/bib/bbag107}
}
EUVIMED